Usefulnes of evaluation of carcinoembryonic antigen (CEA) and soluble fragments of cytokeratin 18-th (TPS) in poostoperative monitoring of patients with colorectal cancer;Przydatność oznaczeń antygenu rakowopłodowego (CEA) i rozpuszczalnych fragmentów cytokeratyny 18-ej (TPS) w pooperacyjnym monitorowaniu chorych na raka okrȩżnicy i odbytnicy

Polski Merkuriusz Lekarski

Volumn 18, Issue 108, 2005, Pages 647-650

  Sandelewski, Artur ^a   Kokocińska, Danuta ^a   Partyka, Robert ^a   Kocot, Jacek ^a   Starzewski, Jacek ^a   Chanek, Izabela ^b   Jałowiecki, Przemysław ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b NONE   (Poland)

Author keywords

CEA; Colorectal cancer; Postoperative monitoring; Reccurence; TPS

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 18; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; COLORECTAL CANCER; CONCENTRATION (PARAMETERS); DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATINS; MALE; MIDDLE AGED; MONITORING, IMMUNOLOGIC; PREDICTIVE VALUE OF TESTS; RECURRENCE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 21944453277     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bates S.H., Longo D.L.: Use of serum tumor markers in cancer diagnosis and management. Semin. Oncol., 1987, 14, 102-138.
2. Berglund A., Molin D., Larsson A. i wsp.: Tumor markers as early predictors of response to chemoterapy in advanced colorectal carcinoma. Annals of Oncology 2002, 13, 1430-1437.
3. Biuletyn statystyczny 1998-1999. Śla̧skie Centrum Zdrowia Publicznego Katowice, 2001, 258.
4. Bjorklund B.: Physiology of cancer as reflected by markers, especially proliferation marker TPS. Anticancer. Res. 1992, 12, 1920-1924.
5. Bjorklund B., Bjorklund V.: The proliferation marker concept with TPS as a model. A preliminary report. J-Nucl-Med-Allied-Sci. 1990, Oct-Dec, 34 (4 Suppl.), 203.
6. Bjorklund B., Bjorklund V.: Biochemishce und morphologische Grundlagen von TPA: Fortschritte in Richtung auf einen allgemienen Marker für aktive Tumoren durch monoklonale kertierung. In: Luthgens M., Schlegel G. (eds): Tumormarkersystem CEA-TPA. TumorDiagnostik, Leonberg, 1987, 14-29.
7. Bombardieri E., Saccani J.G., Cocciolo M.G. i wsp.: Tissue polypeptide antigen and carcionembryonic antigen in colon tumors: serum levels and immunohistochemical localization. Cancer Detect. Prev., 1985, 8, 219-226.
8. Bonfere J., Groenveled E., Korse C. i wsp.: Monoclonal antibody M3 used in tissue polypeptide-specific antigen assay for the quantifiction if tissue polypeptide antigen recognized keratin 18. Tumor Biol., 1994, 15, 210-222.
9. Falcone F., Sabbatani S., Fini A. i wsp.: A Combination of tissue polypeptide antigen (TPA) and carcino embryonic antigen (CEA) in different types of cancer. Nucl. Med. Commun., 1985, May, 6 (5), 299-304.
10. Given M., Scott M., Mc Grath J.P. i wsp.: The predictive of tumour markers CA 15-3, TPS and CEA in breast cancer recurrence. Breast, 2000, Oct, 9 (5), 277-80.
11. Gold P., Freedman S.O.: Specific carcinoembryonic antigens of the human digestive system. J. Exp. Med., 1965, 122, 467.
12. Gonzalez-Quintela A., Mella C., Perez L.F. i wsp.: Increased serum tissue polypeptide specific antigen (TPS) in alcoholics: a possible marker of alcoholic hepatitis. Alcohol Clin. Exp. Res., 2000, Aug, 24 (8), 1222-6.
13. Hobarth K., Hallas A., Kramer G. i wsp.: Tissue polypeptide-specific antigen in renal cell carcinoma. Eur. Urol., 1996, 30 (1), 89-95.
14. Hrycek A., Kokocińska D., Kośmider J. i wsp.: Tissue-polypeptide-specific antigen in SLE patients treated with low doses of quinagolide. Lupus, 2003, 12 (2), 149-52.
15. Hu X.C., Day W., Jones B i wsp.: Comparison of TPS with CEA and CA 15.3 in follow-up of Chinese breast cancer patients. Anticancer Res., 2002, May-Jun, 22 (3), 1865-8.
16. Kokocińska D.: Przygotowanie składników testu radioimmunologicznego i enzymoimmunologicznego dla oznaczania progesteronu; oczyszczanie i frakcjonowanie przeciwciał: IgG, F(ab)'2 przeciw progesteronowi i przeciw ferrytynie dla potrzeb diagnostyki klinicznej. Rozprawa habilitacyjna, Katowice, ŚI. AM., 1993, XVI, 234.
17. Kornek G., Schenk T., Raderer M. i wsp.: Tissue polypeptide-specific antigen (TPS) in monitoring palliative traetment response of patients with gastrointestinal tumors. Br. J. Cancer, 1995, 71, 182-185.
18. Lindmark G., Bergstrom R., Pahlman L. i wsp.: The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer. Brit. J. of Cancer, 1995, 71, 1090-1094.
19. Moraglio D., Pagano M., Galeazzi D. i wsp.: Tissue polypeptide specific antigen (TPS) in liver disease. Clin. Chim. Acta., 1994, Jan 31, 224 (2), 209-14.
20. Nowacki M.P.: Rak jelita grubego. w Onkologia kliniczna. Krzakowski M. (red.), Borgis, Warszawa 2001, tom II, 237-253.
21. Pasanen P.A, Eskelinen M., Partanen K. i wsp.: A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score. Br. J. Cancer, 1994, Mar, 69 (3), 562-565.
22. Rebhandl W., Paya K., Felberbauer F.X. i wsp.: Tissue polyppetide specific antigen (TPS) in pediatric malignancies. Anticancer Res., 1997, 17 (4B), 2865-2868.
23. Rydlander L, Zieglar E, Bergman T i wsp.: Molecular Characteristic of a Tissue-Polyleltide-Specific-Antigen Epitope and its Relationship to Human Cytokertin 18. Eur. J. Biochem. 1996. 241. 309-314.
24. Sedlaczek P., Frydecka I., Gabrys M. i wsp.: Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma. Cancer, 2002, Nov., 1, 95 (9), 1886-1893.
25. Ślesak B., Harłozińska-Szmyrka A., Sedlaczek P. i wsp.: Kliniczna wartość oznaczeń nowego markera proliferacji komórek- TPS w gruczolakorakach i w stanach przedrakowych w jelicie grubym. Gastroenterol. Pol. 1994., 1, 4, 221-225.
26. Van Dalen.: Użyteczność kliniczna kra̧ż acych markerów nowotworowych ze szczególnym uwzglȩdnieniem swoistego tkankowego antygenu polipeptydowego. Diagn. Lab., 1981, 35, 325-36.
27. Wolff J.M., Ronde D., Borchers H. i wsp.: Tissue polypeptide specific antigen serum concentrations in patients with newly diagnosed prostatic diseases. Anticancer Res., 2000, Nov-Dec, 20 (6D), 5003-5.